Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
05/07/2009 | WO2009058769A1 Purification of antibodies containing hydrophobic variants |
05/07/2009 | WO2009030866A3 Method for purifying the factor viii and the von willebrand factor |
05/07/2009 | WO2009019012A3 Immobilisation of chelating groups for immobilised metal ion chromatography (imac) |
05/07/2009 | WO2008051178A3 Purification of proteins with cationic surfactant |
05/07/2009 | WO2007061988A3 Methods for determining notch signaling and uses thereof |
05/07/2009 | WO2007061936A3 Clearance of abnormal iga1 in iga1 deposition diseases |
05/07/2009 | WO2006086404A3 Synovial fluid barrier |
05/07/2009 | WO2006081543A3 Crystalline phosphatase and method for use thereof |
05/07/2009 | WO2006033962A3 Nonlinear spectroscopic methods for identifying and characterizing molecular interactions |
05/07/2009 | WO2006029398A3 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use |
05/07/2009 | WO2006026358A3 Sperm specific raft associated proteins |
05/07/2009 | WO2006017813A3 Methods and compositions for detecting steroids |
05/07/2009 | US20090119027 Method for identifying or characterizing properties of polymeric units |
05/07/2009 | US20090118476 Purification of pegylated polypeptides |
05/07/2009 | US20090118471 Novel coumarin derivatives |
05/07/2009 | US20090118470 Prion Inactivation |
05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
05/07/2009 | US20090118381 Separation of High Density Lipoproteins on Polymer Monoliths with Decreased Hydrophobicity |
05/07/2009 | US20090118172 Shortened glucagon-like peptide 1(sglp-1) preparation method and application |
05/07/2009 | US20090118163 Factor H for the Treatment of Chronic Nephropathies and Production thereof |
05/07/2009 | US20090118135 Methods and compounds for regulating apoptosis |
05/07/2009 | US20090118134 Template Fixed Beta-Hairpin Loop Mimetics and Their Use in Phage Display |
05/07/2009 | US20090117662 Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof |
05/07/2009 | US20090117593 T. Cruzi-derived neurotrophic agents and methods of use therefor |
05/07/2009 | US20090117231 Soy Protein Composition and Beverage Products Containing the Soy Protein Composition |
05/07/2009 | US20090117153 Disulfide Trap MHC Class I Molecules and Uses Therefor |
05/07/2009 | US20090117138 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
05/07/2009 | US20090117103 M-CSF Antibody compositions Having Reduced Levels of Endotoxin |
05/07/2009 | US20090117097 Stabilizer for Protein Preparation Comprising Meglumine and Use Thereof |
05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
05/07/2009 | CA2704774A1 Keratin derivatives and methods of making same |
05/07/2009 | CA2703393A1 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
05/07/2009 | CA2703279A1 Antibody purification by cation exchange chromatography |
05/06/2009 | EP2055723A1 Porous resin particle having hydroxy group or primary amino group and production method thereof |
05/06/2009 | EP2055713A1 Peptide purification by means of metal ion affinity chromatography |
05/06/2009 | EP2055189A1 Glycopegylation methods and proteins/peptides produced by the methods |
05/06/2009 | EP2054521A2 Methods for the purification of polypeptide conjugates |
05/06/2009 | EP1976992A4 Methods and compositions for the detection and isolation of ligands |
05/06/2009 | EP1899375A4 New purification method of lactoferrin |
05/06/2009 | EP1513415B1 Colour reduction in canola protein isolate |
05/06/2009 | EP1309336B1 Derivatives of laspartomycin and preparation and use thereof |
05/06/2009 | CN101423860A Gingeli antioxidation polypeptide composition and method for producing the same |
05/06/2009 | CN101423547A Purification method of teicoplanin |
05/06/2009 | CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof |
05/06/2009 | CN101423545A Method for preparing ginseng water-soluble protein by membrane separation and purification |
05/06/2009 | CN100484954C Method for purifying drug active protein by cation exchange chromatogrphy |
05/05/2009 | US7528240 Method for producing human anti-thymocyte immunoglobulins |
05/05/2009 | US7528234 Conjugating doxorubicin (6-maleimidocaproyl)hydrazone with lactosaminated albumin in the presence of tris(2-carboxyethyl)phosphine reducing agent |
05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
05/05/2009 | US7528228 For use as medicinal products, as intermediates for producing peptides and as a spacer arm in pharmaceutical compositions intended to take biologically active principles specifically to certain cells of the body |
05/05/2009 | US7527952 Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA) |
05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
05/05/2009 | US7527787 Multivalent immunoglobulin-based bioactive assemblies |
05/05/2009 | CA2234980C Cyclopeptide derivatives |
04/30/2009 | WO2009055587A1 Microcoil magnetic resonance detectors |
04/30/2009 | WO2009054226A1 Protein purification method |
04/30/2009 | WO2009053700A1 Modification of nucleic acid-containing biological entities |
04/30/2009 | WO2009053360A1 Method for purifying an fc-containing protein |
04/30/2009 | WO2009053358A1 Method for purifying fc-fusion proteins |
04/30/2009 | WO2009053315A1 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
04/30/2009 | WO2009032978A3 Compositions and methods for diagnosing and treating urinary tract infections |
04/30/2009 | WO2009030780A3 Non-natural proteinaceous scaffold made of three non-covalently associated peptides |
04/30/2009 | WO2009025754A3 Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
04/30/2009 | WO2009024726A3 Method for purifying or detecting a target protein |
04/30/2009 | WO2009017775A3 Process for the preparation of a polypeptide |
04/30/2009 | WO2009010270A3 Purification of pegylated polypeptides |
04/30/2009 | WO2008083150A3 Methods and vectors for generating asialylated immunoglobulins |
04/30/2009 | WO2007126813A3 Cross-reactive monoclonal antibodies recognizing als family proteins |
04/30/2009 | WO2007038619A3 Proteinaceous pharmaceuticals and uses thereof |
04/30/2009 | WO2007027916A9 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
04/30/2009 | WO2007005912A3 Compositions for treating wounds and processes for their preparation |
04/30/2009 | WO2006029125A3 Methods and compositions for treating hypercholesterolemia |
04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
04/30/2009 | US20090111971 treating the unfolded protein with an oxycarbonyl-containing refolding agent selected from formic acid, acetic acid, propionic acid, lactic acid, tartaric acid, citric acid, succinic acid or polyether carboxylic acids and salts, to produce high purity proteins in high productivity |
04/30/2009 | US20090111730 Polypeptide protracting tags |
04/30/2009 | US20090111195 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
04/30/2009 | DE102004044429B4 Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor A process for preparing a composition comprising von Willebrand Factor |
04/30/2009 | CA2703687A1 Microcoil magnetic resonance detectors |
04/30/2009 | CA2703491A1 Tubulysins and processes for preparing |
04/30/2009 | CA2703483A1 Protein based foaming agents and methods of making thereof |
04/30/2009 | CA2703113A1 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
04/30/2009 | CA2703086A1 Method for purifying protein |
04/30/2009 | CA2702448A1 Method for purifying fc-fusion proteins |
04/30/2009 | CA2701283A1 Methods and compositions for obtaining high-resolution crystals of membrane proteins |
04/30/2009 | CA2701221A1 Method for purifying an fc-containing protein |
04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
04/29/2009 | EP2052253A2 Immunogenic compounds and protein mimics |
04/29/2009 | EP2051989A1 One step imac (mcac) purification of proteins |
04/29/2009 | EP2051734A2 Agents for blood-brain barrier delivery |
04/29/2009 | EP1969369A4 Novel capture agents for binding a ligand |
04/29/2009 | EP1487863B1 Process for purifying glycopeptide phospohonate derivatives |
04/29/2009 | EP1115739B1 Auxiliary for amide bond formation |
04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
04/29/2009 | CN101421304A Affinity regions |
04/29/2009 | CN101421291A Process for the manufacture of lysobactin derivatives |
04/29/2009 | CN101418328A Method for producing fish scale collagen protein |
04/29/2009 | CN101418042A Separation and purification of recombinant human blood vessel endothelia cell growth factor, chemical labeling in vitro and use thereof |
04/29/2009 | CN101418041A Transfer factor of anti-swine fever |
04/29/2009 | CN101418035A Novel dipeptide (Boc-Gly-Pro-OH) synthetic process |